Globus Medical Inc (GMED)
84.72
-0.19
(-0.22%)
USD |
NYSE |
Nov 22, 16:00
84.72
0.00 (0.00%)
Pre-Market: 20:00
Globus Medical Free Cash Flow: 293.77M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 293.77M |
| June 30, 2024 | 161.02M |
| March 31, 2024 | 151.72M |
| December 31, 2023 | 165.22M |
| September 30, 2023 | 129.07M |
| June 30, 2023 | 121.05M |
| March 31, 2023 | 117.02M |
| December 31, 2022 | 104.42M |
| September 30, 2022 | 117.99M |
| June 30, 2022 | 156.52M |
| March 31, 2022 | 194.20M |
| December 31, 2021 | 219.38M |
| September 30, 2021 | 226.29M |
| June 30, 2021 | 202.74M |
| March 31, 2021 | 165.05M |
| December 31, 2020 | 135.14M |
| September 30, 2020 | 107.53M |
| June 30, 2020 | 115.41M |
| March 31, 2020 | 110.16M |
| December 31, 2019 | 101.22M |
| September 30, 2019 | 89.84M |
| June 30, 2019 | 82.45M |
| March 31, 2019 | 93.07M |
| December 31, 2018 | 121.95M |
| September 30, 2018 | 126.23M |
| Date | Value |
|---|---|
| June 30, 2018 | 111.79M |
| March 31, 2018 | 105.76M |
| December 31, 2017 | 107.76M |
| September 30, 2017 | 88.48M |
| June 30, 2017 | 102.59M |
| March 31, 2017 | 102.64M |
| December 31, 2016 | 106.91M |
| September 30, 2016 | 126.76M |
| June 30, 2016 | 109.23M |
| March 31, 2016 | 92.00M |
| December 31, 2015 | 73.25M |
| September 30, 2015 | 34.12M |
| June 30, 2015 | 47.77M |
| March 31, 2015 | 58.79M |
| December 31, 2014 | 54.42M |
| September 30, 2014 | 89.02M |
| June 30, 2014 | 84.84M |
| March 31, 2014 | 81.36M |
| December 31, 2013 | 69.79M |
| September 30, 2013 | 59.42M |
| June 30, 2013 | 43.10M |
| March 31, 2013 | 46.80M |
| December 31, 2012 | 51.84M |
| September 30, 2012 | 50.61M |
| June 30, 2012 | 58.57M |
Free Cash Flow Range, Past 5 Years
101.22M
Minimum
Dec 2019
293.77M
Maximum
Sep 2024
154.75M
Average
143.43M
Median
Free Cash Flow Benchmarks
| Boston Scientific Corp | 1.892B |
| Haemonetics Corp | 20.35M |
| ResMed Inc | 1.347B |
| AngioDynamics Inc | -26.58M |
| Stryker Corp | 3.205B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 203.65M |
| Cash from Investing (Quarterly) | -14.97M |
| Cash from Financing (Quarterly) | 19.58M |
| Free Cash Flow Per Share (Quarterly) | 1.171 |
| Free Cash Flow to Equity (Quarterly) | 155.04M |
| Free Cash Flow to Firm (Quarterly) | 162.41M |
| Free Cash Flow Yield | 2.53% |